Klinikum Osnabrueck GmbH — Clinical Trial Site

11 Registered trials

6 Currently recruiting

Organisation

Klinikum Osnabrueck GmbH

Location

Osnabrueck, Germany

Identifier

ORG-100024429

Address

Am Finkenhuegel 1-3, Westerberg, 49076, Germany

Departments

Hematology, Oncology
Klinik für Neurologie und neurologische Frührehabilitation
Klinik für Neurologie und neurologische Frührehabilitation
Medizinische Klinik III
Neurologische Klinik
Neurology

Clinical trials at this site (11)

Search interface

A Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults with Focal Seizures Recruiting

2025-524038-24-00 Focal Epilepsy 5 2026-05-22
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB 3111) Compared With Venetoclax Plus Acalabrutinib in Patients With Pre… Recruiting

2025-524366-21-00 treatment-naive Chronic Lymphocytic Leukemia 5 2026-04-29
A randomized phase III trial assessing iberdomide versus iberdomide plus isatuximab maintenance therapy post autologous hematopoietic stem-c… Recruiting

2023-507402-13-00 Multiple myeloma 5 2024-04-03
A study to determine if BHV-7000 is safe in adults with refractory focal onset epilepsy Recruiting

2023-508813-18-00 Refractory Focal Onset Epilepsy 4 2024-12-18
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy Recruiting

2023-508811-21-00 Refractory Focal Onset Epilepsy 10 2024-09-25
Treatment of Established Status Epilepticus in the Elderly - a prospective, randomized, double-blind comparative effectiveness trial Recruiting

2024-516634-35-00 Convulsive or nonconvulsive benzodiazepine-resistant (e 6 2024-02-01
A randomized phase III trial assessing the benefit of the addition of isatuximab to lenalidomide / bortezomib / dexamethasone (RVd) inductio… Ended

2024-513464-26-00 Multiple Myeloma 5 2018-10-18
A Clinical Phase II, multicenter, Open-label study evaluating iNduction, consolidation and maintenance treatment with Isatuximab (SAR650984)… Ended

2024-511791-32-00 Multiple Myeloma 4 2017-08-15
An Open Label Clinical Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adult Patients with Focal Onset or Primary Generalized Tonic… Ended

2024-517061-16-01 Focal onset seizures or primary generalized tonic-cloni 4 2025-02-27
A double-blind, randomized, placebo-controlled study to evaluate the efficacy, safety, and tolerability of intravenous ganaxolone added to s… Ended

2022-502540-12-00 Refractory Status Epilepticus (RSE) 5 2023-11-09
A randomized phase III non-inferiority trial assessing lenalidomide, bortezomib and dexame-thasone induction therapy with either intravenous… Ended

2024-516300-41-00 Multiple Myeloma 5 2023-03-07